CoChat
Sign Up
Cited by 95

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence

Kimura, Ayano, Hata, Saori, Suzuki, Toshiharu·2016·Journal of Biological Chemistry
DOI 10.1074/jbc.m116.744722
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m116.744722

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 48

  1. Hussain, 1999, Identification of a novel aspartic protease (Asp 2) as β-secretase, Mol. Cell Neurosci, 14, 419, 10.1006/mcne.1999.0811 · DOI · Paper page
  2. Sinha, 1999, Purification and cloning of amyloid precursor protein β-secretase from human brain, Nature, 402, 537, 10.1038/990114 · DOI · Paper page
  3. Yan, 1999, Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity, Nature, 402, 533, 10.1038/990107 · DOI · Paper page
  4. Roher, 1993, Structural alteration in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease, J. Biol. Chem, 268, 3072, 10.1016/S0021-9258(18)53661-9 · DOI · Paper page
  5. Cole, 2008, The role of amyloid precursor protein processing by BACE1, the β-secretase, in Alzheimer's disease pathophysiology, J. Biol. Chem, 283, 29621, 10.1074/jbc.R800015200 · DOI
  6. Thinakaran, 2008, Amyloid precursor protein trafficking, processing, and function, J. Biol. Chem, 283, 29615, 10.1074/jbc.R800019200 · DOI · Paper page
  7. Buxbaum, 1998, Evidence that tumor necrosis factor α converting enzyme is involved in regulated α-secretase cleavage of the Alzheimer amyloid protein precursor, J. Biol. Chem, 273, 27765, 10.1074/jbc.273.43.27765 · DOI
  8. Lammich, 1999, Constitutive and regulated α-secretase cleavage of Alzhemer's amyloid precursor protein by a disintegrin metalloprotease, Proc. Natl. Acad. Sci. U.S.A, 96, 3922, 10.1073/pnas.96.7.3922 · DOI · Paper page
  9. Allinson, 2003, ADAMs family members as amyloid precursor protein α-secretase, J. Neurosci. Res, 74, 342, 10.1002/jnr.10737 · DOI
  10. Liu, 2002, Glu11 site cleavage and N-terminally truncated Aβ production upon BACE overexpression, Biochemistry, 41, 3128, 10.1021/bi015800g · DOI · Paper page
  11. Huse, 2002, β-Secretase processing in the trans-Golgi network preferentially generated truncated amyloid specific that accumulate in Alzheimer's disease brain, J. Biol. Chem, 277, 16278, 10.1074/jbc.M111141200 · DOI · Paper page
  12. Meral, 2013, Discrete molecular dynamics study of oligomer formation by N-terminally truncated amyloid β-protein, J. Mol. Biol, 425, 2260, 10.1016/j.jmb.2013.03.010 · DOI
  13. Jonson, 2015, Systematic Aβ analysis in Drosophila reveals high toxicity for the 1–42, 3–42 and 11–42 peptides, and emphasizes N- and C-terminal residues, PLoS ONE, 10, e0133272, 10.1371/journal.pone.0133272 · DOI
  14. Liu, 2006, Characterization of Aβ11–40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Aβ species in the pathogenesis of Alzheimer's disease, Acta Neuropathol, 112, 163, 10.1007/s00401-006-0077-5 · DOI
  15. Lue, 1999, Soluble amyloid β peptide concentration as a predictor of synaptic change in Alzheimer's disease, Am. J. Pathol, 155, 853, 10.1016/S0002-9440(10)65184-X · DOI · Paper page
  16. McLean, 1999, Soluble pool of Aβ amyloid as determinant of severity of neurodegeneration in Alzheimer's disease, Ann. Neurol, 46, 860, 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · DOI
  17. Lesné, 2013, Brain amyloid-β oligomers in aging and Alzheimer's disease, Brain, 136, 1383, 10.1093/brain/awt062 · DOI
  18. Yan, 2016, Inhibiting BACE1 to reverse synaptic dysfunction in Alzheimer's disease, Neurosci. Biobehav. Rev, 65, 326, 10.1016/j.neubiorev.2016.03.025 · DOI
  19. Zhou, 2011, Amyloid precursor protein mutation E682K at the alternative β-secretase cleavage β′-site increase Aβ generation, EMBO Mol. Med, 3, 291, 10.1002/emmm.201100138 · DOI
  20. Di Fede, 2009, A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis, Science, 323, 1473, 10.1126/science.1168979 · DOI
  21. Suzuki, 2008, Regulation of APP by phosphorylation and protein interactions, J. Biol. Chem, 283, 29633, 10.1074/jbc.R800003200 · DOI
  22. Iijima, 1998, cDNA isolation of Alzheimer's amyloid precursor protein from cholinergic nerve terminals of the electric organ of the electric ray, Biochem. J, 330, 29, 10.1042/bj3300029 · DOI
  23. Motodate, 2016, Expression and localization of X11 family proteins in neurons, Brain Res, 1646, 227, 10.1016/j.brainres.2016.05.054 · DOI
  24. Gouras, 1998, Generation and regulation of β-amyloid peptide variants by neurons, J. Neurochem, 71, 1920, 10.1046/j.1471-4159.1998.71051920.x · DOI
  25. Cai, 2001, BACE1 is the major β-secretase for generation of Aβ peptides by neurons, Nat. Neurosci, 4, 233, 10.1038/85064 · DOI
  26. Vanderstichele, 2005, Amino-truncated β-amyloid42 peptide in cerebrospinal fluid and prediction of progression of mild cognitive impairment, Clin. Chem, 51, 1650, 10.1373/clinchem.2005.051201 · DOI
  27. Johnston, 1994, Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation, FEBS Lett, 354, 274, 10.1016/0014-5793(94)01137-0 · DOI
  28. Messa, 2014, The peculiar role of the A2V mutation in amyloid-β (Aβ) 1–42 molecular assembly, J. Biol. Chem, 289, 24143, 10.1074/jbc.M114.576256 · DOI
  29. Lee, 2005, BACE overexpression alters the subcellular processing of APP and inhibits Aβ deposition in vivo, J. Cell Biol, 168, 291, 10.1083/jcb.200407070 · DOI · Paper page
  30. Tomita, 1998, Cleavage of Alzheimer's amyloid precursor protein by secretases occurs after O-glycosylation of APP in the protein secretory pathway, J. Biol. Chem, 273, 6277, 10.1074/jbc.273.11.6277 · DOI
  31. Fluhrer, 2003, Identification of a β-secretase activity, which truncates amyloid β-peptide after its presenilin-dependent generation, J. Biol. Chem, 278, 5531, 10.1074/jbc.M211485200 · DOI · Paper page
  32. Iwata, 2000, Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition, Nat. Med, 6, 143, 10.1038/72237 · DOI · Paper page
  33. Steiner, 2008, Intramembrane proteolysis by γ-secretase, J. Biol. Chem, 283, 29627, 10.1074/jbc.R800010200 · DOI
  34. Moore, 2012, Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains, Alzheimers Res. Ther, 4, 18, 10.1186/alzrt121 · DOI
  35. Yan, 2014, Targeting the β secretase BACE1 for Alzheimer's disease therapy, Lancet Neurol, 13, 319, 10.1016/S1474-4422(13)70276-X · DOI
  36. Takami, 2009, γ-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of β-carboxyl terminal fragment, J. Neurosci, 29, 13042, 10.1523/JNEUROSCI.2362-09.2009 · DOI · Paper page
  37. Takami, 2012, γ-Secretase-dependent proteolysis of transmembrane domain of amyloid precursor protein: successive tri- and tetrapeptide release in amyloid β-protein production, Int. J. Alzheimers Dis, 10.1155/2012/591392 · DOI
  38. Caillava, 2014, Study on Aβ34 biology and detection in transgenic mice brains, Neurobiol. Aging, 35, 1570, 10.1016/j.neurobiolaging.2014.01.011 · DOI
  39. Iwata, 2001, Metabolic regulation of brain Aβ by neprilysin, Science, 292, 1550, 10.1126/science.1059946 · DOI
  40. Fukumoto, 2002, β-Secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch. Neurol, 59, 1381, 10.1001/archneur.59.9.1381 · DOI · Paper page
  41. Tomita, 1998, A basic amino acid in the cytoplasmic domain of Alzheimer's β-amylid precursor protein (APP) is essential for cleavage of APP at the α-site, J. Biol. Chem, 273, 19304, 10.1074/jbc.273.30.19304 · DOI
  42. Lichtenthaler, 1999, A novel substrate for analyzing Alzheimer's disease γ-secretase, FEBS Lett, 453, 288, 10.1016/S0014-5793(99)00730-9 · DOI
  43. Huse, 2000, Maturation and endosomal targeting of β-site amyloid precursor protein-cleaving enzyme, J. Biol. Chem, 275, 33729, 10.1074/jbc.M004175200 · DOI · Paper page
  44. Hata, 2009, Alcadein cleavages by APP α- and γ-secretases generate small peptides p3-Alcs indicating Alzheimer disease-related γ-secretase dysfunction, J. Biol. Chem, 284, 36024, 10.1074/jbc.M109.057497 · DOI
  45. Piao, 2013, Mechanism of intramembrane cleavage of Alcadeins by γ-secretase, PLoS ONE, 8, e62431, 10.1371/journal.pone.0062431 · DOI
  46. Oishi, 1997, The cytoplasmic domain of the Alzheimer's β-amyloid precursor protein is phosphorylated at Thr-654, Ser-655 and Thr-668 in adult rat brain and cultured cells, Mol. Med, 3, 111, 10.1007/BF03401803 · DOI
  47. Bartlett, 1984, An electron microscopic study of the development of axpns and dendrites by hippocampal neurons in culture: I. cells which develop without intercellular contacts, J. Neurosci, 4, 1944, 10.1523/JNEUROSCI.04-08-01944.1984 · DOI
  48. Chiba, 2014, Quantitative analysis of APP axonal transport in neurons: role of JIP1 in APP anterograde transport, Mol. Biol. Cell, 25, 3569, 10.1091/mbc.e14-06-1111 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kimura, A., Hata, S., & Suzuki, T.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2016-11
Volume
291
Issue
46
Pages
24041-24053
ISSN
0021-9258
DOI
10.1074/jbc.m116.744722
Cited by
95
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review